Screening for colorectal cancer in the United States: Correlates and time trends by type of test
Cancer Epidemiology, Biomarkers & Prevention Jun 09, 2021
Shapiro JA, Soman AV, Berkowitz Z, et al. - Screening for colorectal cancer (CRC) is strongly recommended for adults aged 50-75 years. Colonoscopy, sigmoidoscopy, computed tomography colonography, guaiac fecal occult blood testing (FOBT), fecal immunochemical testing (FIT), or the more recently introduced FIT-DNA (FIT in combination with a stool DNA test) is the recommended screening options. Researchers sought to report on the CRC screening test used for adults aged 50-75 years (N = 10,595). In addition, they determined the time trends in CRC screening test use from 2010-2018. Within recommended time intervals, colonoscopy was the most commonly used test type within 10 years (61.1%), followed by FOBT or FIT in the past year (8.8%), and FIT-DNA within 3 years (2.7%). The percentage up-to-date with CRC screening rose from 61.2% in 2015 to 65.3% in 2018 after age-standardization to the 2010 census population; this was driven by increased use of stool testing, including FIT-DNA. Despite some progress due to a modest rise in stool testing, CRC testing remains low in many population subgroups.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries